Simon Khagi
University of North Carolina at Chapel Hill(US)Hoag Memorial Hospital Presbyterian(US)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Cancer Research and Treatments, CAR-T cell therapy research, Neuroblastoma Research and Treatments, Virus-based gene therapy research
Most-Cited Works
- → First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma(2018)531 cited
- → Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma(2022)373 cited
- → Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial(2023)244 cited
- → Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement(2021)153 cited
- → Fibrin gel enhances the antitumor effects of chimeric antigen receptor T cells in glioblastoma(2021)81 cited
- → Systematic review of combinations of targeted or immunotherapy in advanced solid tumors(2021)79 cited
- → Recent advances in Tumor Treating Fields (TTFields) therapy for glioblastoma(2024)32 cited
- → Tumoricidal stem cell therapy enables killing in novel hybrid models of heterogeneous glioblastoma(2019)31 cited
- → LTBK-04. PHASE 2 MULTICENTER STUDY OF THE ONCOLYTIC ADENOVIRUS DNX-2401 (TASADENOTUREV) IN COMBINATION WITH PEMBROLIZUMAB FOR RECURRENT GLIOBLASTOMA; CAPTIVE STUDY (KEYNOTE-192)(2020)26 cited
- → Intramuscular (IM) INO-5401 + INO-9012 with electroporation (EP) in combination with cemiplimab (REGN2810) in newly diagnosed glioblastoma.(2022)26 cited